Integral Ad Science’s (IAS) Hold Rating Reiterated at Benchmark

Benchmark reiterated their hold rating on shares of Integral Ad Science (NASDAQ:IAS) in a research note released on Thursday,Benzinga reports.

Several other research analysts also recently weighed in on IAS. Barclays upped their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Craig Hallum dropped their price target on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Piper Sandler cut their target price on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a report on Wednesday, November 13th. Oppenheimer cut their target price on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 13th. Finally, Truist Financial lowered their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.70.

Integral Ad Science Trading Down 6.1 %

Shares of IAS stock opened at $10.11 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76. The firm has a market cap of $1.64 billion, a P/E ratio of 50.55, a PEG ratio of 1.40 and a beta of 1.52. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The firm’s 50-day simple moving average is $11.09 and its 200-day simple moving average is $10.48.

Integral Ad Science (NASDAQ:IAS) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same period last year, the business posted ($0.09) EPS. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. As a group, equities analysts forecast that Integral Ad Science will post 0.26 EPS for the current year.

Insider Activity

In related news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the sale, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This represents a 4.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Tania Secor sold 5,240 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $52,976.40. Following the sale, the chief financial officer now owns 248,223 shares of the company’s stock, valued at $2,509,534.53. The trade was a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock worth $240,296 over the last three months. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

Institutional investors and hedge funds have recently modified their holdings of the stock. Point72 DIFC Ltd acquired a new position in shares of Integral Ad Science in the 3rd quarter valued at $41,000. nVerses Capital LLC purchased a new stake in Integral Ad Science during the third quarter valued at about $45,000. Ameritas Investment Partners Inc. boosted its holdings in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after buying an additional 1,924 shares during the period. Quantbot Technologies LP purchased a new position in shares of Integral Ad Science in the third quarter worth approximately $106,000. Finally, XTX Topco Ltd acquired a new stake in shares of Integral Ad Science during the second quarter valued at approximately $113,000. Institutional investors and hedge funds own 95.78% of the company’s stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.